Morepen Laboratories Limited (BOM:500288)
India · Delayed Price · Currency is INR 92.00
-4.80 (-4.96%)
At close: Nov 6, 2026
Morepen Laboratories Market Cap
Morepen Laboratories has a market cap or net worth of 50.41 billion as of November 6, 2026. It is the 13,759th most valuable company in the world and the 837th biggest in India. Its market cap has increased by 90.83% in one year.
Market Cap
50.41B
Enterprise Value
50.94B
Revenue
22.86B
Global Rank
Country Rank
#837 India
PE Ratio
26.67
ChartMarket Cap Chart
Since October 8, 1999, Morepen Laboratories's market cap has increased from 8.66B to 50.41B, an increase of 482.26%. That is a compound annual growth rate of 6.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 50.41B | 124.01% |
| Dec 31, 2025 | 22.50B | -47.55% |
| Dec 31, 2024 | 42.90B | 72.95% |
| Dec 29, 2023 | 24.81B | 28.39% |
| Dec 30, 2022 | 19.32B | -23.70% |
| Dec 31, 2021 | 25.33B | 83.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Viyash Scientific | 100.87B |
| Procter & Gamble Health | 94.75B |
| Sanofi India | 79.47B |
| Bliss GVS Pharma | 66.52B |
| FDC Limited | 63.68B |
| Evonile Pharma | 42.88B |
| Gufic Biosciences | 42.78B |
| Kwality Pharmaceuticals | 38.85B |